The Institute for Advanced Clinical Trials for Children (I-ACT for Children) is pleased to welcome Laura Gordon as Chief Executive Officer. Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development and stakeholder engagement in the public and private healthcare sectors. She most recently was General Manager of the Health, Federal Government Services, Employee Engagement and Multicultural Engagement sectors for the Washington office of Edelman, an independent communications agency with more than 65 offices worldwide.
Ms. Gordon has worked with a host of healthcare professional societies, biopharmaceutical companies and advocacy and community groups, including in pediatrics. She has worked extensively with these groups as well as scientific opinion leaders to build awareness of disorders and fight not only for their proper treatment, but also for more research that could lead to new treatments. She has been responsible for launching strong relationships among biopharmaceutical companies and leading advocacy and professional groups, in large part by helping to design programs that link their interests.
The complete release can be read by clicking here.